Trade Daré Bioscience, Inc. - DARE CFD
Add to favourite- Summary
- Historical Data
Spread | 0.0464 | ||||||||
Long position overnight fee
Long position overnight funding adjustment
Go to platform | -0.023346% | ||||||||
Short position overnight fee
Short position overnight funding adjustment
Go to platform | 0.001124% | ||||||||
Overnight fee time | 21:00 (UTC) | ||||||||
Min traded quantity | 1 | ||||||||
Currency | USD | ||||||||
Margin | 5.00% | ||||||||
Stock exchange | United States of America | ||||||||
Commission on trade | 0% |
Prev. Close | 2.9518 |
Open | 2.9518 |
1-Year Change | 956.48% |
Day's Range | 2.9218 - 2.9618 |
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | Close | Change | Change (%) | Open | High | Low |
---|---|---|---|---|---|---|
Apr 24, 2025 | 2.9518 | 0.0000 | 0.00% | 2.9518 | 2.9618 | 2.9418 |
Apr 23, 2025 | 2.9718 | 0.0500 | 1.71% | 2.9218 | 3.0018 | 2.9218 |
Apr 22, 2025 | 2.9618 | 0.0900 | 3.13% | 2.8718 | 3.0218 | 2.8718 |
Apr 21, 2025 | 2.9318 | 0.0000 | 0.00% | 2.9318 | 2.9518 | 2.8918 |
Apr 17, 2025 | 2.8818 | 0.0000 | 0.00% | 2.8818 | 2.9018 | 2.8818 |
Apr 16, 2025 | 2.9018 | 0.0100 | 0.35% | 2.8918 | 2.9218 | 2.8818 |
Apr 15, 2025 | 2.9318 | 0.0400 | 1.38% | 2.8918 | 2.9618 | 2.8918 |
Apr 14, 2025 | 2.9118 | 0.0200 | 0.69% | 2.8918 | 2.9318 | 2.8818 |
Apr 11, 2025 | 2.9118 | 0.0300 | 1.04% | 2.8818 | 2.9118 | 2.8818 |
Apr 10, 2025 | 2.8818 | -0.0100 | -0.35% | 2.8918 | 2.9018 | 2.8718 |
Apr 9, 2025 | 2.8918 | 0.0200 | 0.70% | 2.8718 | 2.9218 | 2.8718 |
Apr 8, 2025 | 2.8818 | 0.0100 | 0.35% | 2.8718 | 2.9018 | 2.8718 |
Apr 7, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8718 | 2.8718 |
Apr 4, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8818 | 2.8718 |
Apr 3, 2025 | 2.8918 | 0.0100 | 0.35% | 2.8818 | 2.8918 | 2.8718 |
Apr 2, 2025 | 2.9018 | 0.0300 | 1.04% | 2.8718 | 2.9618 | 2.8718 |
Apr 1, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.9118 | 2.8718 |
Mar 31, 2025 | 2.8818 | 0.0100 | 0.35% | 2.8718 | 2.8918 | 2.8718 |
Mar 28, 2025 | 2.8718 | 0.0000 | 0.00% | 2.8718 | 2.8818 | 2.8718 |
Mar 27, 2025 | 2.8818 | 0.0100 | 0.35% | 2.8718 | 2.8818 | 2.8718 |
Trading calculator
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
- 1:1
- 2:1
- 3:1
- 5:1
- 10:1
- 20:1
- 20
- 100
- 500
- 1000
- 10000
Daré Bioscience, Inc. Company profile
Daré Bioscience, Inc., a clinical-stage biopharmaceutical company, focuses on developing and marketing products for women''s health in the United States. The company develops therapies in the areas of contraception, fertility, and sexual and vaginal health. Its products in advanced clinical development include DARE-BV1, a bioadhesive hydrogel formulated with clindamycin phosphate 2% to treat bacterial vaginosis in a single administration that has completed Phase 3 clinical trials; Ovaprene, a hormone-free monthly vaginal contraceptive; and Sildenafil Cream, a cream formulation of sildenafil for topical administration to the vulva and vagina for treatment of female sexual arousal disorder. The company''s Phase 1-ready products are DARE-HRT1, a combination of bio-identical estradiol and progesterone intravaginal ring for the treatment of vasomotor symptoms in hormone therapy; DARE-VVA1, a vaginally delivered formulation of tamoxifen to treat vulvar vaginal atrophy in patients with hormone-receptor positive breast cancer; and DARE-FRT1, an intravaginal ring containing bio-identical progesterone for the prevention of preterm birth and broader luteal phase support as part of an in vitro fertilization treatment plan. Its products in pre-clinical stage include DARE-LARC1, a combination product designed to provide reversible contraception; ORB-204 and ORB-214, an injectable formulations of etonogestrel to provide contraception over 6-month and 12-month periods; and DARE-RH1, a non-hormonal contraception for men and women. The company is headquartered in San Diego, California.Industry: | Biotechnology & Medical Research (NEC) |
3655 Nobel Dr Ste 260
SAN DIEGO
CALIFORNIA 92122-1050
US
News

ECB interest-rate forecasts – Projections for the next five years
The European Central Bank (ECB) plays a pivotal role in the economic stability of the eurozone, meaning ECB interest-rate forecasts are key to understanding how financial and economic scenarios might evolve.
14:37, 10 April 2025
BlackRock shareholders: Who owns the most BLK stock?
BlackRock is the leading asset manager in the world – but who are its biggest shareholders? Read on to find out.
13:46, 9 April 2025
Bitcoin price predictions 2025–2050: third-party price target
We examine bitcoin price predictions for 2025 and beyond, with insights from third-party analysts and market experts.
10:28, 9 April 2025
Tesla (TSLA) stock forecast 2025 and beyond: third-party Tesla price target
Where will Tesla’s stock be in five years? Can the EV company keep its crown?
08:19, 9 April 2025
JasmyCoin price predictions 2025-2030: Third-party price target
How might JASMY behave in the future?
16:13, 8 April 2025
Australian interest-rate projections: where will rates be in 5 years?
As one of the most closely watched economic indicators, Australian interest-rate projections offer valuable insight into the future of the country’s economy.
21:37, 7 April 2025
Copper price forecast: third-party price target
What’s next for the copper market? Read on for the latest analysis of the commodity's price and potential outlook.
17:31, 14 March 2025People also watch
Still looking for a broker you can trust?
Join the 720,000+ traders worldwide that chose to trade with Capital.com